Page 2 - Negma Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Negma pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Negma Pharmaceuticals Today - Breaking & Trending Today

First tranche of GO internet's POC subscribed by Negma

GO internet Spa announced Thursday that Negma Group Investment Ltd has subscribed for the first of 12 tranches of the company s EUR6.0 million convertible bond issue. The first tranche consisted of. | April 13, 2023 ....

Giuseppe Fabio Ciccomascolo , Alliance News Is Italian Service Ltd , Negma Group Investment Ltd , Alliance News , Go Internets Pa Stock Exchange , Press Release , Onsisted Go It0005038002 ,

Mendus redeems the outstanding convertible bonds from Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that the Company has agreed with Negma Group Ltd to redeem the remainder of the first. | April 6, 2023 ....

Mario Brkulj , Corey Davis , Erik Manting , Lifesci Advisors , Negma Group Ltd , Valency Communications , Van Herk Investments , Abuse Regulation , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , He Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible. | April 4, 2023 ....

Mario Brkulj , Erik Manting , Corey Davis , Negma Group , Valency Communications , Lifesci Advisors , Swedish Companies Registration Office , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , F Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 31, 2023 ....

Mario Brkulj , Corey Davis , Erik Manting , Negma Group , Lifesci Advisors , Swedish Companies Registration Office , Valency Communications , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,

Mendus announces request for conversion of convertible bonds by Negma Group

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group has by notice to Mendus requested the conversion of convertible bonds. | March 30, 2023 ....

Mario Brkulj , Erik Manting , Corey Davis , Lifesci Advisors , Swedish Companies Registration Office , Negma Group , Valency Communications , Sci Advisors , Mendus Ab Publ Stock Exchange , Press Release , Onvertible Immu Se0005003654 ,